Transfer Strategy in an Oocyte Donation Programme
Launched by FUNDACION DEXEUS · Mar 18, 2017
Trial Information
Current as of July 08, 2025
Terminated
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Patients under their first or second cycle of a synchronous (fresh) oocyte donation cycle.
- Exclusion Criteria:
- • Preimplantation genetic screening or diagnosis cycles.
- • Patients with strict blastocyst-stage embryo transfer indication by the couple's treating physician.
About Fundacion Dexeus
Fundación Dexeus is a prominent clinical trial sponsor dedicated to advancing medical research and improving patient outcomes through innovative healthcare solutions. Based in Barcelona, Spain, the organization focuses on a wide range of therapeutic areas, particularly in women's health, reproductive medicine, and fertility. With a commitment to ethical practices and rigorous scientific methodologies, Fundación Dexeus collaborates with leading medical professionals and research institutions to conduct high-quality clinical trials. Their mission is to generate valuable data that informs clinical practices, enhances treatment options, and ultimately contributes to the betterment of healthcare globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Barcelona, Barcelons, Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials